台北市信義區5年以上大學以上
About the role:
- Design, develop and implement activities that enable TAKEDA Taiwan to secure optimal reimbursement and realize the maximum commercial potential of current and future products marketed.
- Continuous cross-functional effort which aims to establish and maintain optimal registration, pricing & reimbursement and listing (both at launch and throughout the lifecycle of the product)
- Speed up the product access to the patients; establish/ maintain excellent relationships with Taiwan key public policy makers, influencers, media, NGOs and reimbursement authorities.
How you will contribute:
1) National Pricing and Reimbursement
- Develop various pricing scenario considering product labeling, patient flow, treatment guideline, current competition status, national insurance policy and product life cycle management.
- Develop reimbursement dossier for Takeda new products, new indications, and reimbursement guideline relaxation to ensure value story can be well perceived by payers.
- Conduct price-volume simulation to propose optimal PVA proposal
- Run 5 years revenue forecasts based on different pricing scenarios
- Develop innovative pricing models i.e. risk sharing program, pay for performance, price-volume, price capping…etc and calculate ROIs
- Being the subject matter of expert for Price Right Utility, make sure all the pricing governance can comply with Takeda internal policy properly.
2) Stakeholders Engagement
- Build up network with key stakeholders and maintain regular interactions to dig out the key insights and update to TWLT on regular basis.
- Work with finance dept. to estimate annual price cut impact and simulate the long-term market trend for business planning.
- Regular update market dynamics, macro/micro environment change and policy change to leadership team
- Interface on regular basis with key internal and external stakeholders to review and address their challenges
- Work with IRPMA and related associations to follow up policy and environment change and engage in future policy recommendation
3) Analyze and Shape Payer Market
- Initiate burden of illness studies to understand patient flow, unmet needs, treatment pathways
- Adapt global pharmacoeconomic model with Taiwan local epidemiology and cost data to present Taiwan CEA result. Through this economic value of Takeda’s products can be perceived by payers.
- Develop key stakeholders mapping under reimbursement environment as well as identify key actionable items to drive favorable mindset.
- Conduct the campaigns for increasing disease awareness and sense of urgency of treatment
4) Evidence Based Payer Value Proposition
- Translate insights to innovative payer value propositions from Taiwan payer’s perspective
- Identify evidence requirements and potential data gap to support value story
- Test value story across key stakeholders
- Build relevant, solid value arguments with supporting health economic and budget impact analysis (BIA) models
- Generate PE/HTA reports or conduct CEA model studies
待遇面議